NAS10028,158−0.80%S&P7,572−0.11%GOLD$3,952+1.37%BTC$77,038−1.55%VIX20.69+6.54%latest tape · as of 20:21 UTC
The Screen · Financials · Financial Data & Stock Exchanges
SPGIS&P Global
SPGI · a US exchange · USD · Market cap $133.5B · 44,500 employees
S&P Global Inc., together with its subsidiaries, provides benchmarks, data, analytics, and workflow solutions in the global capital, energy and commodity, and automotive markets.
FAIL · Does not pass the screen
466.55 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 20:21 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Positioning political selling, disclosed 2026-09-25
Options put/call open interest 3.53, read 2026-10-28
Ethical does not pass the values gate
Price466.55 USD
Fair value413.82
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-21Read Markup424.81+9.8% to today ✓Markdown gives way to Markup after a 5% rise in 10 days
2026-10-11Read Markdown403.30+15.7% to today Distribution gives way to Markdown
2026-10-02Read Distribution403.30+15.7% to today Accumulation gives way to Distribution after a 7% slide in 5 weeks
2026-08-30Read Accumulation432.16+8.0% to today ✓Markup gives way to Accumulation while volume is distributing
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
S&P Global holds its Accumulation at $466.55. The statistical read favours the buyers, held for 56 days.
As held on the ledger · 2026-10-30
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 56 days
Price at the screen
$466.55
Valuation
27.52 trailing · 22.83 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.10
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
S&P Global does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SPGI's ethical verdict changes
Today SPGI does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades above our $413.82 fair value estimate, moderate competitive moat.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. The price runs 11.3% above the base estimate.
Third-party analyst targets: 20 covering, consensus Strong Buy. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $413.82, with a range of $413.82 to $475.89, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
S&P Global's Ethical Lapses Outweigh Value
Imagine any financial decision-maker, from a Wall Street analyst to a Main Street investor, and they're likely relying on S&P Global's benchmarks and analytics. The firm is a titan in the financial data and stock exchanges market, offering essential insights in capital, energy, commodity, and automotive sectors. Yet, despite a robust 10% revenue growth and a healthy 31% profit margin, there's a fly in the ointment - its ethical failings.
Why it stands out, or rather, why we pass - S&P Global has a moderate competitive moat and a forward P/E of 21.4x, which might suggest a reasonably valued stock in a growth market. However, its failure on our ethical screen is a critical red flag. When a firm can't meet basic ethical standards, it raises questions about its long-term sustainability and societal value.
The risk here is twofold: the first is the ethical risk, as failing our business activity screen means S&P Global is involved in activities we deem incompatible with our ethical-first approach. The second is the market risk, as the stock is currently trading above our fair value of $413.30, indicating a potential overvaluation. While the consensus rating from analysts is a strong buy with a lofty median target of $523, we cannot overlook the ethical concerns. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SPGI trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Markup$424.81+0.0%Entry 22
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$424.81+0.0%Entry 21
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$424.81+0.0%Entry 20
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$424.81+0.0%Entry 19
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup$424.81+0.0%Entry 18
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markup$424.81+0.0%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markup · changed$424.81+0.0%Entry 16
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$424.81+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$424.81+5.3%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 5.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534.
2026-10-11Markdown · changed$403.30+0.0%Entry 13
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.